Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.
about
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritisPatient reported outcomes in rheumatoid arthritis clinical trialsEstablishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopInvolving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferencesHigh variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort.Reporting of patient-perceived impact of rheumatoid arthritis and axial spondyloarthritis over 10 years: a systematic literature reviewRheumatoid arthritis quality measures and radiographic progression.Pancreatic cancer-improved care achievableAssessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.Fears and beliefs in rheumatoid arthritis and spondyloarthritis: a qualitative study.Is the state of health of rheumatoid arthritis patients receiving adequate treatment, predictable? - Results of a survey.Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach.Fatigue in Egyptian patients with rheumatic diseases: a qualitative studyImpact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trialDepression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy.Patient participation as an integral part of patient-reported outcomes development ensures the representation of the patient voice: a case study from the field of rheumatologyDelayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis.Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID)It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjögren's Syndrome - A qualitative studyIncidence and predictors of secondary fibromyalgia in an early arthritis cohort.Psychometric properties of three single-item pain scales in patients with rheumatoid arthritis seen during routine clinical care: a comparative perspective on construct validity, reproducibility and internal responsiveness.Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and HeDevelopment and preliminary validation of the pancreatic cancer disease impact score.The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version.Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetPatient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?The first national clinical audit for rheumatoid arthritis.Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences--lessons learnt from a decade of collaboration in OMERACT: a qualitative studyDo not forget the professional--the value of the FIRST model for guiding the structural involvement of patients in rheumatology research.Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors.Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.Patient-reported outcomes in core domain sets for rheumatic diseases.Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare.Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes.Flares assessed weekly in patients with rheumatoid arthritis or axial spondyloarthritis and relationship with physical activity measured using a connected activity tracker: a 3-month study.Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.Item Development and Face Validity of the Rheumatoid Arthritis Patient Priorities in Pharmacological Interventions Outcome Measures.
P2860
Q26778271-3A457EDC-3F38-4594-BF0E-37E2C32EB738Q26852960-7453F337-0F38-424F-92F1-A0506F257C0DQ26859493-1FC5184A-0744-4EE4-967C-B27FEC883C66Q30539740-2B7D8BBA-0980-4C7A-9EC1-35B39FE15009Q30890060-91550C1E-A7A8-43D6-ADDE-4012B8A4FA43Q33783951-D09FB44A-D479-4847-BD4B-64DFF3471503Q33953283-30A0B812-0B9D-4EF0-855A-32369C1F589BQ34036659-B6684D77-D44D-49BD-A5F4-738C937C9A6CQ34165218-EABED92B-1C74-469D-B501-EC4EC0495989Q34633743-CCD4B1B0-2A3B-40F3-850D-9F5C26381C85Q35595158-AD4A92F7-7180-4C04-8641-5008201D275FQ35977834-1BC78CA4-7160-4D42-B9A4-E6879AE37E22Q35987071-9FE5BE35-7B29-4F7D-88DA-6B01103DF92DQ36005210-09A4A6BB-CB33-454B-A35E-2BA4E6DFB230Q36098013-CF57142C-AB04-4BC6-83FA-5B3B971FE695Q36182309-80850D31-08C2-4A38-8E60-1881D255BFF4Q36183841-678E141A-7A95-4344-A3D1-A5F4CF44DA61Q36215816-8B99254F-F3D5-4418-80B6-57BE014C7CB3Q36246062-6783002E-9F16-4716-BC04-0142C8CC6380Q36275817-083AA7F3-837D-458D-AB0C-60F6FB365423Q36369191-FCA39B5B-9697-4BA5-9A4F-836F22753473Q36406749-36117764-E22E-4E8E-AA71-A5E8FD8B4D9FQ36489884-88E06A7D-6639-42A0-BB48-2E9A4B803FDBQ36809347-51C87D9C-734C-4109-A6AF-0BBA3744D0ECQ36833558-6BC931B9-9D6F-45F9-9D2D-1F35755B9FDAQ36947638-BCB0AAB5-98CE-47F2-A157-C41D6C51632BQ37065115-40295AFD-7598-4600-AF2D-FDA1A7ED280AQ37087708-11BF8B5C-2887-4F4B-A4A9-DE38A5B6AB91Q37121643-54E5C23F-429F-446B-89F3-9E9F709B9A94Q37333319-6F56ED21-8D39-464A-A02D-6273570CE288Q37704288-52BDAE47-7D4E-4647-B6B2-6E0529340234Q38213143-07D52563-E941-4711-8D48-C299351F1C04Q38577796-CBCA69CB-0608-46E2-8168-34453293EAC3Q39048368-53648A1E-BE4F-4493-B7C6-1FDFA07C5D61Q39330884-094A81FA-88A9-411C-A6F4-BFD1707FAE80Q39381766-86AB08C5-2B17-45D2-A30E-BEE882EEB102Q39672360-2D670AD7-718E-4B1D-946A-9F640EB38772Q40054572-941DC848-39CA-4D38-A9E6-9861A7F70C8DQ40062771-DDE23C19-7EFE-4D09-9BD6-2D0B6E844316Q40795254-566A366F-9F9F-4EB4-B64F-4394A82104C0
P2860
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Finalisation and validation of ...... arthritis: a EULAR initiative.
@en
Finalisation and validation of ...... arthritis: a EULAR initiative.
@nl
type
label
Finalisation and validation of ...... arthritis: a EULAR initiative.
@en
Finalisation and validation of ...... arthritis: a EULAR initiative.
@nl
prefLabel
Finalisation and validation of ...... arthritis: a EULAR initiative.
@en
Finalisation and validation of ...... arthritis: a EULAR initiative.
@nl
P2093
P50
P356
P1476
Finalisation and validation of ...... arthritis: a EULAR initiative.
@en
P2093
A Balanescu
B A C Dijkmans
C Hernandez
D T Boumpas
E Martin Mola
G J Aanerud
G von Krause
P304
P356
10.1136/ARD.2010.142901
P407
P577
2011-06-01T00:00:00Z